<DOC>
	<DOCNO>NCT03062254</DOCNO>
	<brief_summary>Broadly , objective study evaluate fractional decline intensity tracer uptake measure SUVmax 68Ga-PSMA PET/CT bone metastasis prostate cancer follow treatment radium-223 surrogate marker tumor cell kill .</brief_summary>
	<brief_title>Metabolic Change Prostate Cancer Bone Metastases 68Ga-HBED-CC-PSMA ( DKFZ-11 ) PET/CT Following Radium-223 Therapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Radium Ra 223 dichloride</mesh_term>
	<criteria>Inclusion Criteria Resident Canada Male sex Age 18 year older Progressive ( symptom , conventional imaging , PSA , bone scan , FCH PET/CT ) castrationresistant prostate cancer judgment treat physician without change systemic antineoplastic therapy since document progression Six great bone metastases robustlyavid recent ( 4 week ) MDP NaF scintigraphy Recently fail ( within 3 month ) fail novel androgen receptor pathway inhibitor ( abiraterone + prednisone enzalutamide ) intention continue drug least 7 month OR minimum 14 day washout period either agent prior study enrollment No known visceral metastasis adenopathy great 3 cm short axis conventional imaging Not receive docetaxel castrationresistant disease ECOG performance status 0 2 , inclusive Life expectancy great 6 month Serum testosterone less equal 50 ng/dl Hemoglobin great equal 100 g/L blood transfusion EPO precede 3 week Neutrophils great equal 1.5 x109/L Platelets great equal 100 x109/L No prior hemibody radiotherapy No impend establish spinal cord compression No unmanageable fecal incontinence Patient good IV access Able understand provide write informed consent Exclusion Criteria Planned change systemic antineoplastic therapy approximately 7 month trial Unable tolerate physical/logistical requirement PET/CT scan include lie supine 30 minute arm head tolerate intravenous cannulation injection study drug . Medically unstable patient ( e.g . acute cardiac respiratory distress hypotensive , etc . ) Patients exceed safe weight limit PET/CT bed ( approximately 400 lb . ) fit PET/CT bore ( 70 cm diameter ) Patients claustrophobic</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PSMA</keyword>
</DOC>